Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 12:10PM
From IR this morning:
The disease process increases activation of inflammatory responses and apabetalone decreases it; in this context, the words (reduces/corrects/downregulates) can be interchangeable.